靖遠煤電(000552.SZ):劉化化工擬吸收合併農升化工 並獲公司1億元增資
格隆匯9月28日丨靖遠煤電(000552.SZ)公佈,為了提升公司化工板塊產業鏈協同效益,降低管理成本,優化治理結構,提高運營效率,根據全資子公司靖遠煤業集團劉化化工有限公司(簡稱“劉化化工”)在建項目靖遠煤電清潔高效氣化氣綜合利用(搬遷改造)項目一期工程需要,擬由劉化化工吸收合併白銀農升化工有限責任公司(簡稱“農升化工”),包括農升化工全部資產、負債、權益及業務,並授權劉化化工負責辦理相關事宜。吸收合併完成後,劉化化工作為合併方存續經營,農升化工依法註銷。
同時,根據經營需要,公司擬以自有資金1億元對劉化化工增加出資,專項用於合併後原農升化工日常運營流動資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.